Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effect of ursodeoxycholic acid on duodenal permeability and meal-related sensory motor function in functional dyspepsia
2016-003631-37Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ursodeoxycholic acid in functional dyspepsia (FD), sponsored by UZ Leuven. Primary endpoint: Duodenal permeability and meal related sensory motor function. Started Dec 2016; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2016-003631-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003631-37.